Supplementary Tables 1 Through 8 from Immune Escape in Breast Cancer During in Situ to Invasive Carcinoma Transition
Carlos R. Gil Del Alcazar,Sung Jin Huh,Muhammad B. Ekram,Anne Trinh,Lin L. Liu,Francisco Beca,Xiaoyuan Zi,Minsuk Kwak,Helga Bergholtz,Ying Su,Lina Ding,Hege G. Russnes,Andrea L. Richardson,Kirsten Babski,Elizabeth Min Hui Kim,Charles H. McDonnell,Jon Wagner,Ron Rowberry,Gordon J. Freeman,Deborah Dillon,Therese Sorlie,Lisa M. Coussens,Judy E. Garber,Rong Fan,Kristie Bobolis,D. Craig Allred,Joon Jeong,So Yeon Park,Franziska Michor,Kornelia Polyak
DOI: https://doi.org/10.1158/2159-8290.22531784
2023-01-01
Abstract:Supplementary Table S1. List of tissue samples used. Supplementary Table S2. Raw FACS data in each sample. Supplementary Table S3. List of differentially expressed genes. Supplementary Table S4. Results of GSEA analyses. Supplementary Table S5. Gene lists used for functional analyses. Supplementary Table S6. Statistical modeling of ERBB2 and CC co-amplification; and PDL1 amplification. Supplementary Table S7. ERBB2 and 17q12 FISH data. Supplementary Table S8. List of antibodies used.